×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Kriterien zur Bestimmung der zweckmäßigen ... · IQWiG, 2016 [9,10]. Nivolumab (Nierenzellkarzinom) – Nutzenbewertung gemäß § 35a SGB V (IQWiG-Berichte – Nr. 415) Zugelassenes
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form